Insider Holders & Insider Ownership - PLUS THERAPEUTICS INC. (PSTV)

List of insiders holdings for PLUS THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Lim Kian Thiam
10% Owner		2015-04-20 15:27:057,400,000
0		7,400,000Form 4
OLYMPUS CORP
10% Owner		2014-09-16 06:01:153,973,043
0		3,973,043Form 13D
PostFinance AG
10% Owner		2018-05-24 16:16:072,795,561
0		2,795,561Form 13G
Saad Mark E
Chief Financial Officer		2014-04-15 16:03:451,228,430
0		1,228,430Form 4
SHIRAHAMA NORIO SEIJIRO
President - Asia Pacific		2015-02-03 19:29:24881,159
0		881,159Form 4
COX MARSHALL G
Director		2007-02-28 17:34:31480,000
0		480,000Form 4
HENRIKSEN RONALD D
Director		2012-01-04 19:12:26438,592
0		438,592Form 4
REUTER BRUCE
SVP Sales, Market., Distr.		2009-02-02 16:55:15394,686
0		394,686Form 4
SCHULZKI SHARON
Chief Operating Officer		2005-02-04 19:20:34380,000
0		380,000Form 4
Swissquote Bank SA
10% Owner		2018-08-28 11:11:40376,723
0		376,723Form 13G
GALETTO CHARLES
Sr. Vice President Finance & A		2006-01-26 16:56:35280,000
0		280,000Form 4
Arm Douglas M
Sr. VP - Operations		2009-05-04 20:33:40185,000
0		185,000Form 4
SCARBROUGH ELIZABETH
Vice President Marketing & Dev		2006-01-26 17:16:02176,250
0		176,250Form 4
FRASER JOHN K
Vice President Research & Tech		2005-02-04 16:46:59166,250
0		166,250Form 4
SCOTT MATTHEW
Vice President Sales		2004-06-04 17:46:43165,000
0		165,000Form 4
Milstein Alexander M
VP - Clinical Development		2009-02-02 16:57:24155,000
0		155,000Form 4
CALHOUN CHRISTOPHER J
Chief Executive Officer		2014-01-14 18:11:01118,125
36,850		154,975Form 4
Townsend John
Controller		2015-02-03 19:30:39139,850
0		139,850Form 4
Thompson Tommy G
Director		2016-01-04 17:55:54136,950
0		136,950Form 4
Ransom John T
VP Research Regn. Cell Techn.		2007-02-28 18:00:20105,000
0		105,000Form 4
HEDRICK MARC H
Chief Executive Officer		2024-02-26 18:26:0894,012
0		94,012Form 4
Dean Lloyd H
Director		2014-05-20 12:17:0551,059
40,000		91,059Form 4
HOLMES E CARMACK
Director		2014-05-20 12:09:1219,517
37,401		56,918Form 4
MARTELL RON
Director		2017-01-27 17:46:0950,000
0		50,000Form 4
LAPOINTE ANTHONY GREGG
Director		2017-05-24 16:35:4550,000
0		50,000Form 4
Jona Ruud J.P.
Director		2014-06-12 16:25:5342,000
0		42,000Form 4
HAYDEN JEREMY B.
General Counsel & VP of BD		2017-03-17 17:08:1931,100
0		31,100Form 4/A
Marino Mark
Chief Medical Officer		2017-03-17 17:10:4831,100
0		31,100Form 4/A
HAWRAN PAUL W
Director		2017-01-27 17:48:4325,000
0		25,000Form 4
LaFrance Norman D.
Chief Medical Officer		2024-02-26 18:26:3124,073
0		24,073Form 4
Sims Andrew John Hugh MacIntyre
Chief Financial Officer		2024-02-26 18:25:4518,933
0		18,933Form 4
RICKEY DAVID
Director		2017-11-29 17:40:0710,806
0		10,806Form 4
KESTEN STEVEN
Exec VP and Chief MO		2016-06-15 18:56:213581
400		3981Form 4
Petersen Greg
Director		2024-02-26 18:23:152250
0		2250Form 4
Hawkins Richard J
Director		2024-02-26 18:24:182250
0		2250Form 4
van Es-Johansson An
Director		2024-02-26 18:24:442250
0		2250Form 4
Lenk Robert P
Director		2024-02-26 18:25:142250
0		2250Form 4
Clowes Howard
Director		2024-02-26 18:27:072250
0		2250Form 4
LYONS GARY A
Director		2018-02-09 16:54:031801
0		1801Form 4
HARRIS JOHN DAVID
VP and GM Cell Therapy		2017-11-29 17:34:411801
0		1801Form 4
Naughton Gail K
Director		2017-11-29 17:39:061801
0		1801Form 4
Girao Tiago
VP & Chief Financial Officer		2018-07-27 16:31:451051
0		1051Form 4